These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Effective Priming of Herpes Simplex Virus-Specific CD8 Whitney PG; Makhlouf C; MacLeod B; Ma JZ; Gressier E; Greyer M; Hochheiser K; Bachem A; Zaid A; Voehringer D; Heath WR; Wagle MV; Parish I; Russell TA; Smith SA; Tscharke DC; Gebhardt T; Bedoui S J Virol; 2018 Feb; 92(3):. PubMed ID: 29142130 [TBL] [Abstract][Full Text] [Related]
10. Herpes simplex virus type 1 glycoproteins gB, gC and gD are major targets for CD4 T-lymphocyte cytotoxicity in HLA-DR expressing human epidermal keratinocytes. Mikloska Z; Cunningham AL J Gen Virol; 1998 Feb; 79 ( Pt 2)():353-61. PubMed ID: 9472620 [TBL] [Abstract][Full Text] [Related]
13. A Herpes Simplex Virus Type 1 Human Asymptomatic CD8+ T-Cell Epitopes-Based Vaccine Protects Against Ocular Herpes in a "Humanized" HLA Transgenic Rabbit Model. Srivastava R; Khan AA; Huang J; Nesburn AB; Wechsler SL; BenMohamed L Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):4013-28. PubMed ID: 26098469 [TBL] [Abstract][Full Text] [Related]
14. Unique Type I Interferon, Expansion/Survival Cytokines, and JAK/STAT Gene Signatures of Multifunctional Herpes Simplex Virus-Specific Effector Memory CD8 Vahed H; Agrawal A; Srivastava R; Prakash S; Coulon PA; Roy S; BenMohamed L J Virol; 2019 Feb; 93(4):. PubMed ID: 30487281 [TBL] [Abstract][Full Text] [Related]
15. A Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus (HSV) Type 2 Vaccine, HSV529, in Adults With or Without HSV Infection. Dropulic LK; Oestreich MC; Pietz HL; Laing KJ; Hunsberger S; Lumbard K; Garabedian D; Turk SP; Chen A; Hornung RL; Seshadri C; Smith MT; Hosken NA; Phogat S; Chang LJ; Koelle DM; Wang K; Cohen JI J Infect Dis; 2019 Aug; 220(6):990-1000. PubMed ID: 31058977 [TBL] [Abstract][Full Text] [Related]
16. Herpes simplex virus antigens directly activate NK cells via TLR2, thus facilitating their presentation to CD4 T lymphocytes. Kim M; Osborne NR; Zeng W; Donaghy H; McKinnon K; Jackson DC; Cunningham AL J Immunol; 2012 May; 188(9):4158-70. PubMed ID: 22467654 [TBL] [Abstract][Full Text] [Related]
17. Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets. Maccario R; Comoli P; Percivalle E; Montagna D; Locatelli F; Gerna G Immunology; 1995 May; 85(1):49-56. PubMed ID: 7635521 [TBL] [Abstract][Full Text] [Related]
18. Reevaluating the CD8 T-cell response to herpes simplex virus type 1: involvement of CD8 T cells reactive to subdominant epitopes. Sheridan BS; Cherpes TL; Urban J; Kalinski P; Hendricks RL J Virol; 2009 Mar; 83(5):2237-45. PubMed ID: 19073721 [TBL] [Abstract][Full Text] [Related]
19. CD4+ T cells are required for the priming of CD8+ T cells following infection with herpes simplex virus type 1. Rajasagi NK; Kassim SH; Kollias CM; Zhao X; Chervenak R; Jennings SR J Virol; 2009 May; 83(10):5256-68. PubMed ID: 19279095 [TBL] [Abstract][Full Text] [Related]
20. Development of an interferon-gamma ELISPOT assay to detect human T cell responses to HSV-2. Posavad CM; Magaret AS; Zhao L; Mueller DE; Wald A; Corey L Vaccine; 2011 Sep; 29(40):7058-66. PubMed ID: 21801778 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]